Dr Georgios Kalamakis, PhD, is a joint postdoctoral fellow between ETH Zurich and the Novartis Institute for BioMedical Research (NIBR). He obtained a master’s degree in neural and behavioural sciences from the University of Tübingen, Germany, and did his PhD research in the German Cancer Research Center (DKFZ) in Heidelberg, where he studied the impact of ageing on neural stem cells in the murine brain. Dr Kalamakis has always been interested in high-throughput screening, which led him to join the Laboratory for Biological Engineering (ETH Zurich) and the Functional Genetics laboratory (NIBR), where he performs various genetic screens using the CRISPR/Cas9 system.